Switch to:
Hi-Tech Pharmacal Co., Inc. (NAS:HITK)
EV/EBIT
14.05 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Hi-Tech Pharmacal Co., Inc.'s enterprise value is $518.4 Mil. Hi-Tech Pharmacal Co., Inc.'s operating income for the trailing twelve months (TTM) ended in Jan. 2014 was $36.9 Mil. Therefore, Hi-Tech Pharmacal Co., Inc.'s EV/EBIT ratio for today is 14.05.

HITK' s 10-Year EV/EBIT Range
Min: 3.4   Max: 418.2
Current: 14.05

3.4
418.2

During the past 13 years, the highest EV/EBIT Ratio of Hi-Tech Pharmacal Co., Inc. was 418.20. The lowest was 3.40. And the median was 9.70.

HITK's EV/EBITis ranked higher than
90% of the 806 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 32.97 vs. HITK: 14.05 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Hi-Tech Pharmacal Co., Inc.'s enterprise value for the quarter that ended in Jan. 2014 was $514.9 Mil. Hi-Tech Pharmacal Co., Inc.'s Operating Income for the trailing twelve months (TTM) ended in Jan. 2014 was $36.9 Mil. Hi-Tech Pharmacal Co., Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jan. 2014 was 7.16%.


Definition

Hi-Tech Pharmacal Co., Inc.'s EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=518.368/36.888
=14.05

Hi-Tech Pharmacal Co., Inc.'s current Enterprise Value is $518.4 Mil.
Hi-Tech Pharmacal Co., Inc.'s Operating Income for the trailing twelve months (TTM) ended in Jan. 2014 was 7.433 (Apr. 2013 ) + 6.866 (Jul. 2013 ) + 10.961 (Oct. 2013 ) + 11.628 (Jan. 2014 ) = $36.9 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Hi-Tech Pharmacal Co., Inc.'s Earnings Yield (Joel Greenblatt) for the quarter that ended in Jan. 2014 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Jan. 2014 )=Operating Income (TTM)/Enterprise Value (Q: Jan. 2014 )
=36.888/514.867
=7.16 %

Hi-Tech Pharmacal Co., Inc.'s Enterprise Value for the quarter that ended in Jan. 2014 was $514.9 Mil.
Hi-Tech Pharmacal Co., Inc.'s Operating Income for the trailing twelve months (TTM) ended in Jan. 2014 was 7.433 (Apr. 2013 ) + 6.866 (Jul. 2013 ) + 10.961 (Oct. 2013 ) + 11.628 (Jan. 2014 ) = $36.9 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Hi-Tech Pharmacal Co., Inc. Annual Data

Apr04Apr05Apr06Apr07Apr08Apr09Apr10Apr11Apr12Apr13
ev2ebit 13.0511.8017.890.000.006.196.014.804.979.34

Hi-Tech Pharmacal Co., Inc. Quarterly Data

Oct11Jan12Apr12Jul12Oct12Jan13Apr13Jul13Oct13Jan14
ev2ebit 5.195.934.976.396.469.519.3410.6314.0513.96
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide